
Apellis Pharmaceuticals, Inc.
USD41.03
+0.00 (+0.00%)
CEO
Cedric Francois
IPO Date
2017-11-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$41.05
Prev. Close
$41.03
Day Low
$41.03
Day High
$41.05
52W Low
$16.61
52W High
$41.14
Market Cap
$5.25B
Volume
28.64M
| 20 Sept 2024 |
| Mizuho |
| Neutral |
| Neutral |
| maintain |
| 13 Sept 2024 | JP Morgan | Overweight | Overweight | maintain |
| 13 Aug 2024 | JP Morgan | Overweight | Overweight | maintain |
| 9 Aug 2024 | Needham | Buy | Buy | maintain |
| 9 Aug 2024 | Wedbush | Neutral | Neutral | maintain |
| 9 Aug 2024 | Goldman Sachs | Buy | Buy | maintain |
| 9 Aug 2024 | UBS | Buy | Buy | maintain |